Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study Using the CliniMACS® Device for T-Cell Receptor (TCR) αβ+CD3+/CD19+ Depleted Hematopoietic Stem Cells for Patients Undergoing Transplant

NCT05968170 is registered in ClinicalTrials.gov with Neena Kapoor, M.D. as lead sponsor.

NCT NCT05968170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05968170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study Using the CliniMACS® Device for T-Cell Receptor (TCR) αβ+CD3+/CD19+ Depleted Hematopoietic Stem Cells for Patients Undergoing Transplant
Lead sponsor
Neena Kapoor, M.D.
Phase
Not applicable
Overall status
Withdrawn
Start date
May 27, 2025
Completion date
July 1, 2035
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, acute myeloid leukemia, graft vs host disease, graft-versus-host-disease, hematologic malignancy, non-hematologic malignancy